Back to search

Article

Genetic downregulation of interleukin-6 signaling and arteriolosclerotic cerebral small vessel disease: a drug target Mendelian randomization analysis

2024-12-14

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Arteriolosclerotic cerebral small vessel disease (cSVD) is a leading cause of stroke and dementia, yet no disease-modifying therapies exist. Anti-inflammatory strategies targeting IL- 6 signaling have shown efficacy in preventing atherosclerotic cardiovascular disease, but their potential in arteriolosclerotic cSVD remains unexplored. We investigated whether genetically downre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
702dc73c-2c09-5807-a140-93802abc08b2
DOI
10.1101/2024.12.13.24318994
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genetic downregulation of interleukin-6 signaling and arteriolosclerotic cerebral small vessel disease: a drug target Mendelian randomization analysisDOI 10.1101/2024.12.13.24318994
Select a neighboring publication to make it the new centre.